We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+10.72%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.85B
AUM Growth
+$338M
Cap. Flow
+$79.4M
Cap. Flow %
1.36%
Top 10 Hldgs %
45.51%
Holding
707
New
76
Increased
198
Reduced
354
Closed
64

Top Buys

Rank Stock Value
1
TER icon
Teradyne
TER
+$60.1M
2
TSLA icon
Tesla
TSLA
+$32.1M
3
TSEM icon
Tower Semiconductor
TSEM
+$29.6M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$29M
5
PDD icon
Pinduoduo
PDD
+$28.1M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$77.7M
2
BE icon
Bloom Energy
BE
+$53.1M
3
HOOD icon
Robinhood
HOOD
+$24.9M
4
SAP icon
SAP
SAP
+$24.1M
5
BIDU icon
Baidu
BIDU
+$21.5M

Sector Composition

Rank Sector Weight
1 Technology 51.21%
2 Communication Services 15.38%
3 Consumer Discretionary 13.01%
4 Healthcare 6.62%
5 Consumer Staples 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HPP
576
Hudson Pacific Properties
HPP
$758M
$9.84K ﹤0.01%
909
-5
-0.5% -$74
LENZ
577
LENZ Therapeutics
LENZ
$179M
$9.71K ﹤0.01%
607
-7
-1% -$204
DELL icon
578
Dell
DELL
$239B
$9.69K ﹤0.01%
+77
New +$10.8K
CBL
579
CBL Properties
CBL
$1.84B
$9.55K ﹤0.01%
258
-1
-0.4% -$33
BIOA
580
BioAge Labs
BIOA
$986M
$9.31K ﹤0.01%
+704
New +$6.24K
MRVI icon
581
Maravai LifeSciences
MRVI
$972M
$9.26K ﹤0.01%
2,849
-264
-8% -$889
LKFT
582
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$9.22K ﹤0.01%
282
-23
-8% -$743
ETON icon
583
Eton Pharmaceutcials
ETON
$1.32B
$8.91K ﹤0.01%
+527
New +$9.27K
ENTA icon
584
Enanta Pharmaceuticals
ENTA
$362M
$8.91K ﹤0.01%
565
+117
+26% +$1.49K
AHRT
585
AH Realty Trust
AHRT
$536M
$8.79K ﹤0.01%
1,328
+30
+2% +$198
PEPG icon
586
PepGen
PEPG
$118M
$8.79K ﹤0.01%
1,350
+671
+99% +$3.48K
INN
587
Summit Hotel Properties
INN
$766M
$8.78K ﹤0.01%
1,803
-77
-4% -$403
SLDB icon
588
Solid Biosciences
SLDB
$792M
$8.63K ﹤0.01%
1,530
-145
-9% -$786
SIGA icon
589
SIGA Technologies
SIGA
$240M
$8.59K ﹤0.01%
1,406
-123
-8% -$875
NVTS icon
590
Navitas Semiconductor
NVTS
$2.54B
$8.56K ﹤0.01%
+1,199
New +$11.5K
EOLS icon
591
Evolus
EOLS
$397M
$8.46K ﹤0.01%
1,273
-119
-9% -$806
FDMT icon
592
4D Molecular Therapeutics
FDMT
$502M
$8.41K ﹤0.01%
1,122
+117
+12% +$1.19K
IMRX icon
593
Immuneering
IMRX
$262M
$8.34K ﹤0.01%
+1,268
New +$8.14K
ALX
594
Alexander's
ALX
$1.36B
$8.28K ﹤0.01%
38
– –
GOOD
595
Gladstone Commercial Corp
GOOD
$623M
$8.21K ﹤0.01%
769
-3
-0.4% -$33
NBP
596
NovaBridge Biosciences American Depositary Shares
NBP
$186M
$8.13K ﹤0.01%
+2,042
New +$9.04K
KYTX icon
597
Kyverna Therapeutics
KYTX
$430M
$8.08K ﹤0.01%
860
-38
-4% -$282
KMDA icon
598
Kamada
KMDA
$404M
$8K ﹤0.01%
+1,133
New +$7.84K
AUTL
599
Autolus Therapeutics
AUTL
$389M
$7.84K ﹤0.01%
3,941
-320
-8% -$492
TRDA icon
600
Entrada Therapeutics
TRDA
$254M
$7.72K ﹤0.01%
751
-56
-7% -$472
22 23
24
25 26

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return

GF Fund Management's Q4 2025 Portfolio in Review

As of Q4 2025, GF Fund Management held 707 positions worth $5.85B, up 6.1% from $5.51B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

GF Fund Management's Q4 2025 filing shows 76 new, 198 increased, 354 reduced and 64 closed positions. Its largest new stake was Teradyne: 350,137 shares worth $67.8M. The largest sale was Broadcom, an estimated $77.7M.

By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 49% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q4 2025 buy was Teradyne: 350,137 shares worth $67.8M.
  • GF Fund Management added most to Tesla in Q4 2025, an estimated $32.1M increase.
  • GF Fund Management's biggest Q4 2025 reduction was Broadcom, cutting an estimated $77.7M.
  • GF Fund Management fully exited Baidu in Q4 2025, selling an estimated $21.5M.
  • GF Fund Management's ten largest holdings make up 46% of its $5.85B portfolio in Q4 2025.
  • GF Fund Management opened 76 new positions and closed 64 in Q4 2025.
  • GF Fund Management's portfolio value rose 6.1% quarter-over-quarter to $5.85B.

Based on GF Fund Management's 13F filing for Q4 2025, filed 27 Jan 2026.